Who's speaking
- Jill Knerath — host
Chapters
- 0:00Prognostic Factors in Favorable Histology Wilms Tumor with Lung Metastases — Overview of a 2025 COG study examining how tumor burden and biological markers affect outcomes in favorable histology Wilms tumor patients with pulmonary metastases, with focus on nodule characteristics versus chromosomal abnormalities.
Key claims
- 0:14Dick et al. published a report from a Children's Oncology Group study in the Journal of Clinical Oncology in 2025 — Jill Knerath
- 0:19The study examined factors in patients with favorable histology Wilms tumor and pulmonary metastases and how those factors may affect outcomes — Jill Knerath
- 0:30Factors studied included the number of metastases, the size of the metastases, and different biological markers — Jill Knerath
- 0:36There was no difference in survival based on the number of metastases — Jill Knerath
- 0:41Patients who had a rapid response to chemotherapy with larger nodules showed worse event-free survival — Jill Knerath
- 0:41Patients with larger nodules and rapid response to chemotherapy showed no changes in overall survival — Jill Knerath
- 0:49In multivariable models, neither the size nor the number of nodules had any effect on survival — Jill Knerath
- 0:551q gain was associated with worse event-free survival — Jill Knerath
- 0:551q gain was associated with worse overall survival — Jill Knerath
- 1:041q gain is the superior prognostic factor when compared to size and number of nodules in patients with favorable histology Wilms tumor and pulmonary metastases — Jill Knerath
Open questions
- Do these results surprise you?
This episode was analyzed and enriched by
Kai, the Library's AI content creator. Every item links to the
moment it comes from — click a timestamp to listen in context.